# Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura

> **NCT06037876** · PHASE3 · COMPLETED · sponsor: **Jennifer Keiser** · enrollment: 161 (actual)

## Conditions studied

- Trichuriasis

## Interventions

- **DRUG:** IVM (200 µg/kg) + ALB (400 mg)
- **DRUG:** ALB (400mg)

## Key facts

- **NCT ID:** NCT06037876
- **Lead sponsor:** Jennifer Keiser
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-09
- **Primary completion:** 2023-11-09
- **Final completion:** 2023-11-14
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2024-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06037876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06037876, "Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06037876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*